ASND Stock Price
Ascendis Pharma A/S
ASND stock price is $227.00 (+1.70% on the day), giving Ascendis Pharma A/S a market cap of $14.96B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ASND Stock Overview
- Price
- $227.00
- Previous close
- $223.21
- Open
- $222.54
- Market cap
- $14.96B
- P/E ratio
- -39.6
- 52-week range
- $186.05 - $282.15
- 1-year price target
- $314.75
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 38
About Ascendis Pharma A/S
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It also develops a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. Ascendis Pharma A/S was incorporated in 2006 and is headquartered in Hellerup, Denmark.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASND | $227.00 | +1.7% | 995.63K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |